Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. May 3, 2018. Patricia Zilliox.

Executive Summary

See what opthalmic industry veteran and Eyevensys CEO Patricia Zilliox said about the opportunity for her firm's technology to target eye diseases at this year's BioTrinity 2018 in London.

"I've been working in ophthalmology for 25 years and looking for a technology like this. Everything has been tried, and I've worked on everything, so when I saw this project, I thought this technology was a complete game changer, as we're using the ciliary muscle in the eye as a factory to manufacture proteins on an ongoing basis." – Patricia Zilliox, CEO, Eyevensys

Click here for a free trial of Medtech Insight

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT122600

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel